AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.2 Market Size Estimation
2.3 Market Share Estimation
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Limitations
2.6.1 Methodology-Related Limitations
2.6.2 Scope-Related Limitations
2.7 Risk Assessment

4.1 Artificial Intelligence in Precision Medicine Market Overview
4.2 Artificial Intelligence in Precision Medicine Market, by Region
4.3 North America: Artificial Intelligence in Precision Medicine Market, by End-user & Region
4.4 Artificial Intelligence in Precision Medicine Market: Geographic Snapshot
4.5 Artificial Intelligence in Precision Medicine Market: Developed vs. Emerging Markets

5.1 Introduction
5.2 Market Dynamics
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increase in Investments in R&D and Rise in Demand for Personalized Medication
5.3.1.2 Advancements in Genomic Research and Data Availability
5.3.1.3 Growth in Cross-Industry Collaborations and Partnerships
5.3.1.4 Role of Regulatory Landscape in Driving AI Adoption in Healthcare
5.3.2 Restraints
5.3.2.1 Increase in Data Breach Concerns
5.3.2.2 High Cost of Implementation of Precision Medicine Solutions
5.3.2.3 Accuracy Challenges in AI Adoption for Healthcare
5.3.3 Opportunities
5.3.3.1 Role of Predictive Analytics in Advancing AI for Healthcare
5.3.3.2 Leveraging Research Pipelines and New Drug Development for AI in Healthcare
5.3.4 Challenges
5.3.4.1 Impact of Fairness and Bias on AI in Healthcare
5.3.4.2 Interoperability Challenges due to Complexity of AI Solutions
5.4 Trends/Disruptions Impacting Customer Businesses
5.5 Industry Trends
5.5.1 AI's Growing Role in Patient-Specific Data Integration and Analysis
5.5.2 Advancements in AI-Powered Predictive Analytics for Treatment Optimization
5.6 Ecosystem Analysis
5.7 Value Chain Analysis
5.8 Technology Analysis
5.8.1 Key Technologies
5.8.1.1 Predictive Analytics
5.8.1.2 Neural Networks
5.8.1.3 Knowledge Graphs
5.8.1.4 Cell and Gene Therapies
5.8.1.5 AI-Driven Single-Cell Analysis
5.8.2 Complementary Technology
5.8.2.1 High-Performance Computing (Hpc)
5.8.2.2 Next-Generation Sequencing
5.8.2.3 Real-World Evidence/Real-World Data
5.8.2.4 Ehr Integration
5.8.2.5 Digital Health Platforms
5.8.3 Adjacent Technologies
5.8.3.1 Cloud Computing
5.8.3.2 Blockchain Technology
5.8.3.3 Internet of Things (IoT) and Wearables
5.8.3.4 Robotics and Automation
5.8.3.5 3D Printing for Personalized Implants and Devices
5.9 Regulatory Analysis
5.9.1 Regulatory Bodies, Government Agencies, and Other Organizations
5.9.2 Regulatory Scenario
5.10 Pricing Analysis
5.10.1 Indicative Pricing for Key Players
5.10.2 Indicative Price of Key Components, by Region
5.11 Porter's Five Forces Analysis
5.11.1 Threat of New Entrants
5.11.2 Threat of Substitutes
5.11.3 Bargaining Power of Suppliers
5.11.4 Bargaining Power of Buyers
5.11.5 Intensity of Competitive Rivalry
5.12 Patent Analysis
5.12.1 Patent Publication Trends
5.12.2 Jurisdiction Analysis: Top Applicant Countries for AI in Precision Medicine
5.12.3 Key Patents in AI in Precision Medicine Market
5.13 Key Stakeholders and Buying Criteria
5.13.1 Key Stakeholders in Buying Process
5.13.2 Key Buying Criteria
5.14 End-user Analysis
5.14.1 Unmet Needs
5.14.2 End-user Expectations
5.15 Key Conferences & Events
5.16 Case Study Analysis
5.16.1 Sanofi Leveraged AI-Driven Precision Medicine to Identify Patient Subtypes and Novel Targets in Inflammatory Bowel Disease
5.16.2 IBM's AI-Driven Solution Improved Clinical Trial Enrollment at Mayo Clinic by Enhancing Patient Matching
5.16.3 Enhancing Patient Identification for Rare Oncology Biomarkers Through Genomic Testing and Strategic Collaboration
5.17 Investment and Funding Scenario
5.18 Business Models
5.19 Impact of AI/Gen AI in Precision Medicine Market
5.19.1 Key Use Cases
5.19.2 Case Studies of AI/Generative AI Implementation
5.19.2.1 Enhancing Patient Outcomes with AI-Driven Predictive Analytics at Johns Hopkins Hospital
5.19.3 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
5.19.3.1 AI in Drug Discovery Market
5.19.3.2 Genomics Market
5.19.3.3 Artificial Intelligence Market
5.19.3.4 Pharmacogenomics Market
5.19.4 User Readiness and Impact Assessment
5.19.4.1 User Readiness
5.19.4.1.1 Healthcare Providers
5.19.4.1.2 Pharmaceutical & Biotechnology Companies

6.1 Introduction
6.2 Drug Discovery & Development
6.2.1 Drug Discovery
6.2.2 Understanding Diseases
6.2.2.1 Rise in Data Mining to Link Targets to Diseases
6.2.3 Drug Repurposing
6.2.3.1 Use of Graphs for Targeted Approach to Reduce Timelines and Costs
6.2.4 De Novo Drug Design
6.2.4.1 Availability of Large-Scale Biomedical Datasets and Urgent Demand for Novel Treatments for Complex Diseases
6.2.5 Drug Optimization
6.2.5.1 Need to Process Extensive Data on Molecular Properties, Target Interactions, and Clinical Outcomes
6.2.6 Safety & Toxicity
6.2.6.1 Building Generalizable Model for Toxicity and Off-Target Effect Prediction
6.2.7 Clinical Development
6.2.7.1 Designing and Conducting Clinical Trials for Personalized Dosing, Targeted Therapies
6.3 Diagnostics & Screening
6.3.1 Risk Assessment & Patient Stratification
6.3.1.1 Leveraging AI to Personalize Treatment Plan
6.3.2 Disease Screening
6.3.2.1 Leveraging Machine Learning to Peruse and Resolve Complex Patient Data
6.3.3 Disease Diagnosis
6.3.3.1 Identifying Biomarkers for Precise Treatment
6.3.4 Disease Progression, Staging, and Prognosis
6.3.4.1 Using AI to Track Disease Conditions
6.4 Therapeutics
6.4.1 Therapy Selection & Planning
6.4.1.1 Leveraging Generative Models to Predict and Design Suitable Treatment
6.4.2 Therapy Monitoring
6.4.2.1 Need to Effectively Track Safety and Efficacy of Treatment
6.4.3 Post-Treatment Surveillance & Follow-Up
6.4.3.1 AI Algorithms to Identify Subtle Patterns in Data, Allowing for Early Detection of Potential Issues

7.1 Introduction
7.2 Oncology
7.2.1 High Prevalence of Cancer and Shortage of Effective Cancer Drugs
7.3 Rare Diseases
7.3.1 Combating Challenging Therapeutics due to Complex and Heterogeneous Nature of Rare Diseases
7.4 Infectious Diseases
7.4.1 Need for Innovation in Infectious Disease Treatment, Especially After Impact of COVID-19
7.5 Neurology
7.5.1 Shortage and Complexity of Neurodegenerative Diseases
7.6 Cardiology
7.6.1 Wide Range and Incidence of Cardiovascular Diseases
7.7 Hematology
7.7.1 AI-Driven Algorithms to Analyze Blood Samples, Imaging Data, and Genomic Profiles to Detect Abnormalities
7.8 Other Therapeutic Areas

8.1 Introduction
8.2 Software
8.2.1 Scalability and Flexibility of AI Software to Enhance Efficiency of Clinical Workflows
8.3 Services
8.3.1 Need for Expert Assistance Among Healthcare Organizations in Adopting and Optimizing AI Technologies

9.1 Introduction
9.2 Machine Learning
9.2.1 Deep Learning
9.2.1.1 Convolutional Neural Networks
9.2.1.1.1 Interpreting Complex Biological Data to Enable Personalizing Healthcare
9.2.1.2 Recurrent Neural Networks (Rnns)
9.2.1.2.1 Optimizing Clinical Data to Model Patient Trajectories by Analyzing Longitudinal Data
9.2.1.3 Generative Adversarial Networks (Gans)
9.2.1.3.1 Gan to Focus on New Molecules and Biological Datasets
9.2.1.4 Graph Neural Networks (Gnns)
9.2.1.4.1 Predicting Drug-Drug Interactions to Optimize Personalized Treatment
9.2.1.5 Other Deep Learning Tools
9.2.2 Supervised Machine Learning
9.2.3 Reinforcement Machine Learning
9.2.4 Unsupervised Machine Learning
9.2.5 Other Machine Learning Tools
9.3 Natural Language Processing
9.3.1 Abundance of Unstructured Data in Clinical Research to be Interpreted
9.4 Context-Aware Processing & Computing
9.4.1 Tailoring Patient Care in Real Time to Enhance Precision Medicine
9.5 Computer Vision
9.5.1 Increase in Use of Imaging Biomarkers to Support Surgical Precision
9.6 Image Analysis
9.6.1 Harnessing Machine Learning to Automate Techniques Such as Quantitative Imaging and Radiomics
9.7 Other Tools

10.1 Introduction
10.2 Cloud-based Model
10.2.1 Research Collaboration and Cost-Efficiency of Cloud Deployment
10.3 On-Premise Model
10.3.1 Easier to Secure Patient Data and Ensure Compliance in On-Premise AI-Driven Precision Medicine
10.4 Hybrid Model
10.4.1 Hybrid Models to Enhance Flexibility and Security

11.1 Introduction
11.2 Healthcare Providers
11.2.1 Revolutionizing Patient Care and Treatment Delivery Through Advanced Technologies
11.3 Pharmaceutical & Biotechnology Companies
11.3.1 Driving Drug Development Efficiency to Design Adaptive Trial Protocols and Optimize Treatment
11.4 Medical Device & Equipment Companies
11.4.1 Integration of AI in Medical Devices to Enhance Precision and Personalized Healthcare
11.5 Research Centers, Academic Institutes, and Government Organizations
11.5.1 AI in Academic Institutes and Public Sector Collaborations to Accelerate Innovation and Research
11.6 Other End-users

12.1 Introduction
12.2 North America
12.2.1 North America: Macroeconomic Outlook
12.2.2 US
12.2.2.1 US to Dominate North American Market with Advanced Regulatory System
12.2.3 Canada
12.2.3.1 Emergence of New AI-based Startups and High Health Expenditure
12.3 Europe
12.3.1 Europe: Macroeconomic Outlook
12.3.2 UK
12.3.2.1 Favorable Government R&D Investment and Collaborations Focused on Drug Discovery
12.3.3 Germany
12.3.3.1 Growing R&D Investment by Pharma and Biotech Companies
12.3.4 France
12.3.4.1 Strong Government Support Through Investments in Initiatives
12.3.5 Italy
12.3.5.1 Government Initiatives Addressing Local Healthcare Challenges Through Studies Aimed at Broader Precision Medicine Strategies
12.3.6 Spain
12.3.6.1 High Investments by Pharmaceutical Companies
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Asia-Pacific: Macroeconomic Outlook
12.4.2 Japan
12.4.2.1 High Investment in R&D and Government Initiatives Focused on Treatment Outcomes
12.4.3 China
12.4.3.1 Government Funding to Advance Data Analysis and International Collaborations to Develop Targeted Therapies
12.4.4 India
12.4.4.1 High Growth of Pharmaceutical and Medical Device Industries
12.4.5 Rest of Asia-Pacific
12.5 Latin America
12.5.1 Latin America: Macroeconomic Outlook
12.5.2 Brazil
12.5.2.1 Increase in Governmental Support Through Initiatives Such as Brazilian Artificial Intelligence Plan
12.5.3 Mexico
12.5.3.1 High Potential to Become Leader in Terms of Readiness in Technology
12.5.4 Rest of Latin America
12.6 Middle East & Africa
12.6.1 Middle East & Africa: Macroeconomic Outlook
12.6.2 GCC Countries
12.6.2.1 Increasing Emphasis on Personalized Medicines and Developing Healthcare Infrastructure
12.6.3 Rest of Middle East & Africa

13.1 Introduction
13.2 Key Player Strategy/Right to Win
13.3 Revenue Analysis, 2019-2023
13.4 Market Share Analysis, 2023
13.4.1 Ranking of Key Market Players
13.5 Company Evaluation Matrix: Key Players, 2023
13.5.1 Stars
13.5.2 Emerging Leaders
13.5.3 Pervasive Players
13.5.4 Participants
13.5.5 Company Footprint: Key Players, 2023
13.5.5.1 Company Footprint
13.5.5.2 Therapeutic Area Footprint
13.5.5.3 End-user Footprint
13.5.5.4 Component Footprint
13.5.5.5 Deployment Footprint
13.5.5.6 Region Footprint
13.6 Company Evaluation Matrix: Startups/SMEs, 2023
13.6.1 Progressive Companies
13.6.2 Responsive Companies
13.6.3 Dynamic Companies
13.6.4 Starting Blocks
13.6.5 Competitive Benchmarking: Startups/SMEs, 2023
13.6.5.1 Detailed List of Key Startup/SME Players
13.6.5.2 Competitive Benchmarking of Key Emerging Players/Startups, by Region
13.7 Company Valuation and Financial Metrics
13.7.1 Company Valuation
13.7.2 Financial Metrics
13.8 Brand/Product Comparison
13.9 Competitive Scenario
13.9.1 Product Launches
13.9.2 Deals
13.9.3 Expansions
13.9.4 Other Developments

14.1 Key Players
14.1.1 Nvidia Corporation
14.1.1.1 Business Overview
14.1.1.2 Products/Services/Solutions Offered
14.1.1.3 Recent Developments
14.1.1.3.1 Product Launches
14.1.1.3.2 Deals
14.1.1.4 Analyst's View
14.1.1.4.1 Right to Win
14.1.1.4.2 Strategic Choices
14.1.1.4.3 Weaknesses & Competitive Threats
14.1.2 Exscientia
14.1.2.1 Business Overview
14.1.2.2 Products/Services/Solutions Offered
14.1.2.3 Recent Developments
14.1.2.3.1 Product Launches
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.3.4 Other Developments
14.1.2.4 Analyst's View
14.1.2.4.1 Right to Win
14.1.2.4.2 Strategic Choices
14.1.2.4.3 Weaknesses and Competitive Threats
14.1.3 Google
14.1.3.1 Business Overview
14.1.3.2 Products/Services/Solutions Offered
14.1.3.3 Recent Developments
14.1.3.3.1 Product Launches
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 Analyst's View
14.1.3.4.1 Right to Win
14.1.3.4.2 Strategic Choices
14.1.3.4.3 Weaknesses and Competitive Threats
14.1.4 Illumina, Inc.
14.1.4.1 Business Overview
14.1.4.2 Products/Services/Solutions Offered
14.1.4.3 Recent Developments
14.1.4.3.1 Product Launches
14.1.4.3.2 Deals
14.1.4.4 Analyst's View
14.1.4.4.1 Right to Win
14.1.4.4.2 Strategic Choices
14.1.4.4.3 Weaknesses and Competitive Threats
14.1.5 Tempus AI, Inc.
14.1.5.1 Business Overview
14.1.5.2 Products/Services/Solutions Offered
14.1.5.3 Recent Developments
14.1.5.3.1 Product Launches
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.3.4 Other Developments
14.1.5.4 Analyst's View
14.1.5.4.1 Right to Win
14.1.5.4.2 Strategic Choices
14.1.5.4.3 Weaknesses and Competitive Threats
14.1.6 Benevolentai
14.1.6.1 Business Overview
14.1.6.2 Products/Services/Solutions Offered
14.1.6.3 Recent Developments
14.1.6.3.1 Deals
14.1.7 Microsoft Corporation
14.1.7.1 Business Overview
14.1.7.2 Products/Services/Solutions Offered
14.1.7.3 Recent Developments
14.1.7.3.1 Deals
14.1.8 IBM
14.1.8.1 Business Overview
14.1.8.2 Products/Services/Solutions Offered
14.1.8.3 Recent Developments
14.1.8.3.1 Deals
14.1.9 GE Healthcare
14.1.9.1 Business Overview
14.1.9.2 Products/Services/Solutions Offered
14.1.9.3 Recent Developments
14.1.9.3.1 Product Launches
14.1.9.3.2 Deals
14.1.9.3.3 Other Developments
14.1.10 Deep Genomics
14.1.10.1 Business Overview
14.1.10.2 Products/Services/Solutions Offered
14.1.10.3 Recent Developments
14.1.10.3.1 Product Launches
14.1.10.3.2 Deals
14.1.10.3.3 Other Developments
14.1.11 Siemens Healthineers AG
14.1.11.1 Business Overview
14.1.11.2 Products/Solutions/Services Offered
14.1.11.3 Recent Developments
14.1.11.3.1 Deals
14.1.12 Bioxcel Therapeutics, Inc.
14.1.12.1 Business Overview
14.1.12.2 Products/Solutions/Services Offered
14.1.12.3 Recent Developments
14.1.12.3.1 Deals
14.1.12.3.2 Other Developments
14.1.13 Insilico Medicine
14.1.13.1 Business Overview
14.1.13.2 Products/Services/Solutions Offered
14.1.13.3 Recent Developments
14.1.13.3.1 Product Launches
14.1.13.3.2 Deals
14.1.13.3.3 Other Developments
14.1.14 Pathai, Inc.
14.1.14.1 Business Overview
14.1.14.2 Products/Services/Solutions Offered
14.1.14.3 Recent Developments
14.1.14.3.1 Product Launches
14.1.14.3.2 Deals
14.1.14.3.3 Other Developments
14.1.15 Verge Genomics
14.1.15.1 Business Overview
14.1.15.2 Products/Services/Solutions Offered
14.1.15.3 Recent Developments
14.1.15.3.1 Deals
14.1.16 Guardant Health, Inc.
14.1.16.1 Business Overview
14.1.16.2 Products/Services/Solutions Offered
14.1.16.3 Recent Developments
14.1.16.3.1 Product Launches
14.1.16.3.2 Deals
14.1.16.3.3 Other Developments
14.1.17 Grail, Inc.
14.1.17.1 Business Overview
14.1.17.2 Products/Services/Solutions Offered
14.1.17.3 Recent Developments
14.1.17.3.1 Deals
14.1.18 Foundation Medicine, Inc.
14.1.18.1 Business Overview
14.1.18.2 Products/Services/Solutions Offered
14.1.18.3 Recent Developments
14.1.18.3.1 Deals
14.1.18.3.2 Other Developments
14.1.19 Proscia Inc.
14.1.19.1 Business Overview
14.1.19.2 Products/Services/Solutions Offered
14.1.19.3 Recent Developments
14.1.19.3.1 Product Launches
14.1.19.3.2 Deals
14.1.19.3.3 Other Developments
14.1.20 Flatiron Health
14.1.20.1 Business Overview
14.1.20.2 Products/Services/Solutions Offered
14.1.20.3 Recent Developments
14.1.20.3.1 Deals
14.1.20.3.2 Other Developments
14.2 Other Players
14.2.1 Predictive Oncology
14.2.2 Paige AI, Inc.
14.2.3 Densitas Inc.
14.2.4 Zephyr AI, Inc.
14.2.5 Nucleai, Inc.

15.1 Discussion Guide
15.2 Knowledgestore: The Subscription Portal
15.3 Customization Options

Table 1 AI in Precision Medicine Market: Inclusions & Exclusions
Table 2 Artificial Intelligence in Precision Medicine Market Dynamics: Impact Analysis
Table 3 Indicative List of Collaborations and Partnerships, 2021-2024
Table 4 Biggest Healthcare Security Breaches, 2023
Table 5 AI in Drug Discovery Market: Role in Ecosystem
Table 6 North America: List of Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 North America: Regulatory Scenario
Table 13 Europe: Regulatory Scenario
Table 14 Asia-Pacific: Regulatory Scenario
Table 15 Middle East & Africa: Regulatory Scenario
Table 16 Latin America: Regulatory Scenario
Table 17 Indicative Pricing for Key Players, 2023 (USD)
Table 18 Indicative Price of Key Components, by Region, 2022-2024 (USD)
Table 19 AI in Precision Medicine Market: Porter's Five Forces Analysis
Table 20 Jurisdiction Analysis of Top Applicant Countries for AI in Precision Medicine
Table 21 AI in Precision Medicine Market: List of Patents/Patent Applications
Table 22 Influence of Stakeholders on Buying Process of Top Three End-users
Table 23 Key Buying Criteria for Top Three End-users
Table 24 Unmet Needs in AI in Precision Medicine Market
Table 25 End-user Expectations in AI in Precision Medicine Market
Table 26 Key Conferences & Events, 2024-2025
Table 27 Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 28 Artificial Intelligence in Precision Medicine Market for Drug Discovery & Development, by Application, 2022-2030 (USD Million)
Table 29 Artificial Intelligence in Precision Medicine Market for Drug Discovery, by Application, 2022-2030 (USD Million)
Table 30 Artificial Intelligence in Precision Medicine Market for Understanding Diseases, by Country/Region, 2022-2030 (USD Million)
Table 31 Artificial Intelligence in Precision Medicine Market for Drug Repurposing, by Country/Region, 2022-2030 (USD Million)
Table 32 Artificial Intelligence in Precision Medicine Market for De Novo Drug Design, by Country/Region, 2022-2030 (USD Million)
Table 33 Artificial Intelligence in Precision Medicine Market for Drug Optimization, by Country/Region, 2022-2030 (USD Million)
Table 34 Artificial Intelligence in Precision Medicine Market for Safety & Toxicity, by Country/Region, 2022-2030 (USD Million)
Table 35 Artificial Intelligence in Precision Medicine Market for Clinical Development, by Country/Region, 2022-2030 (USD Million)
Table 36 Artificial Intelligence in Precision Medicine Market for Diagnostics & Screening, by Type, 2022-2030 (USD Million)
Table 37 Artificial Intelligence in Precision Medicine Market for Risk Assessment & Patient Stratification, by Country/Region, 2022-2030 (USD Million)
Table 38 Artificial Intelligence in Precision Medicine Market for Disease Screening, by Country/Region, 2022-2030 (USD Million)
Table 39 Artificial Intelligence in Precision Medicine Market for Disease Diagnosis, by Country/Region, 2022-2030 (USD Million)
Table 40 Artificial Intelligence in Precision Medicine Market for Disease Progression, Staging, and Prognosis, by Country/Region, 2022-2030 (USD Million)
Table 41 Artificial Intelligence in Precision Medicine Market for Therapeutics, by Type, 2022-2030 (USD Million)
Table 42 Artificial Intelligence in Precision Medicine Market for Therapy Selection & Planning, by Country/Region, 2022-2030 (USD Million)
Table 43 Artificial Intelligence in Precision Medicine Market for Therapy Monitoring, by Country/Region, 2022-2030 (USD Million)
Table 44 Artificial Intelligence in Precision Medicine Market for Post-Treatment Surveillance & Follow-Up, by Country/Region, 2022-2030 (USD Million)
Table 45 Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 46 Artificial Intelligence in Drug Discovery Market for Oncology, By Country/Region, 2022-2030 (USD Million)
Table 47 Artificial Intelligence in Precision Medicine Market for Rare Diseases, by Country/Region, 2022-2030 (USD Million)
Table 48 Artificial Intelligence in Precision Medicine Market for Infectious Diseases, by Country/Region, 2022-2030 (USD Million)
Table 49 Artificial Intelligence in Precision Medicine Market for Neurology, By Country/Region, 2022-2030 (USD Million)
Table 50 Indicative List of Developments in Cardiology
Table 51 Artificial Intelligence in Precision Medicine Market for Cardiology, By Country/Region, 2022-2030 (USD Million)
Table 52 Artificial Intelligence in Precision Medicine Market for Hematology, by Country/Region, 2022-2030 (USD Million)
Table 53 Artificial Intelligence in Precision Medicine Market for Other Therapeutic Areas, by Country/Region, 2022-2030 (USD Million)
Table 54 Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 55 Artificial Intelligence in Precision Medicine Market for Software, By Country/Region, 2022-2030 (USD Million)
Table 56 Artificial Intelligence Services in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 57 AI in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 58 Machine Learning in Precision Medicine Market, by Type, 2022-2030 (USD Million)
Table 59 Machine Learning in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 60 Deep Learning in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 61 Convolutional Neural Networks in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 62 Recurrent Neural Networks in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 63 Generative Adversarial Networks in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 64 Graph Neural Networks in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 65 Other Deep Learning Tools in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 66 Supervised Learning in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 67 Reinforcement Learning in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 68 Unsupervised Learning in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 69 Other Machine Learning Tools in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 70 Natural Language Processing in Precision Medicine Market, By Country/Region, 2022-2030 (USD Million)
Table 71 Context-Aware Processing & Computing in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 72 Computer Vision AI in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 73 Image Analysis in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 74 Other AI Tools in Precision Medicine Market, by Country/Region, 2022-2030 (USD Million)
Table 75 Artificial Intelligence in Precision Medicine Market, by Deployment, 2022-2030 (USD Million)
Table 76 Artificial Intelligence in Precision Medicine Market for Cloud-based Model, by Country/Region, 2022-2030 (USD Million)
Table 77 Artificial Intelligence in Precision Medicine Market for On-Premise Model, by Country/Region, 2022-2030 (USD Million)
Table 78 Artificial Intelligence in Precision Medicine Market for Hybrid Model, by Country/Region, 2022-2030 (USD Million)
Table 79 Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 80 Artificial Intelligence in Precision Medicine Market for Healthcare Providers, by Country/Region, 2022-2030 (USD Million)
Table 81 Artificial Intelligence in Precision Medicine Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2030 (USD Million)
Table 82 Artificial Intelligence in Precision Medicine Market for Medical Device & Equipment Companies, by Country/Region, 2022-2030 (USD Million)
Table 83 Artificial Intelligence in Precision Medicine Market for Research Centers, Academic Institutes, and Government Organizations, by Country/Region, 2022-2030 (USD Million)
Table 84 Artificial Intelligence in Precision Medicine Market for Other End-users, by Country/Region, 2022-2030 (USD Million)
Table 85 Artificial Intelligence in Precision Medicine Market, by Region, 2022-2030 (USD Million)
Table 86 North America: Artificial Intelligence in Precision Medicine Market, By Country, 2022-2030 (USD Million)
Table 87 North America: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 88 North America: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 89 North America: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 90 North America: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 91 North America: Artificial Intelligence in Precision Medicine Market, By Deployment 2022-2030 (USD Million)
Table 92 North America: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 93 US: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 94 US: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 95 US: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 96 US: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 97 US: Artificial Intelligence in Precision Medicine Market, by Deployment 2022-2030 (USD Million)
Table 98 US: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 99 Canada: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 100 Canada: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 101 Canada: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 102 Canada: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 103 Canada: Artificial Intelligence in Precision Medicine Market, By Deployment 2022-2030 (USD Million)
Table 104 Canada: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 105 Europe: Artificial Intelligence in Precision Medicine Market, By Country, 2022-2030 (USD Million)
Table 106 Europe: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 107 Europe: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 108 Europe: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 109 Europe: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 110 Europe: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 111 Europe: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 112 UK: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 113 UK: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 114 UK: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 115 UK: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 116 UK: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 117 UK: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 118 Germany: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 119 Germany: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 120 Germany: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 121 Germany: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 122 Germany: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 123 Germany: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 124 France: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 125 France: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 126 France: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 127 France: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 128 France: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 129 France: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 130 Italy: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 131 Italy: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 132 Italy: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 133 Italy: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 134 Italy: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 135 Italy: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 136 Spain: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 137 Spain: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 138 Spain: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 139 Spain: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 140 Spain: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 141 Spain: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 142 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 143 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 144 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 145 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 146 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 147 Rest of Europe: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 148 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Country, 2022-2030 (USD Million)
Table 149 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 150 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 151 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 152 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 153 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 154 Asia-Pacific: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 155 Japan: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 156 Japan: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 157 Japan: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 158 Japan: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 159 Japan: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 160 Japan: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 161 China: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 162 China: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 163 China: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 164 China: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 165 China: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 166 China: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 167 India: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 168 India: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 169 India: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 170 India: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 171 India: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 172 India: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 173 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 174 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 175 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 176 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 177 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by Deployment, 2022-2030 (USD Million)
Table 178 Rest of Asia-Pacific: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 179 Latin America: Artificial Intelligence in Precision Medicine Market, By Region, 2022-2030 (USD Million)
Table 180 Latin America: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 181 Latin America: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 182 Latin America: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 183 Latin America: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 184 Latin America: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 185 Latin America: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 186 Brazil: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 187 Brazil: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 188 Brazil: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 189 Brazil: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 190 Brazil: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 191 Brazil: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 192 Mexico: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 193 Mexico: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 194 Mexico: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 195 Mexico: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 196 Mexico: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 197 Mexico: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 198 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 199 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 200 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 201 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 202 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by Deployment, 2022-2030 (USD Million)
Table 203 Rest of Latin America: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 204 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Region, 2022-2030 (USD Million)
Table 205 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 206 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 207 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 208 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 209 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Deployment, 2022-2030 (USD Million)
Table 210 Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 211 GCC Countries: Artificial Intelligence in Precision Medicine Market, By Application, 2022-2030 (USD Million)
Table 212 GCC Countries: Artificial Intelligence in Precision Medicine Market, By Therapeutic Area, 2022-2030 (USD Million)
Table 213 GCC Countries: Artificial Intelligence in Precision Medicine Market, By Component, 2022-2030 (USD Million)
Table 214 GCC Countries: Artificial Intelligence in Precision Medicine Market, By Tool, 2022-2030 (USD Million)
Table 215 GCC Countries: Artificial Intelligence in Precision Medicine Market, By Deployment, 2022-2030 (USD Million)
Table 216 GCC Countries: Artificial Intelligence in Precision Medicine Market, By End-user, 2022-2030 (USD Million)
Table 217 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Application, 2022-2030 (USD Million)
Table 218 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2022-2030 (USD Million)
Table 219 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Component, 2022-2030 (USD Million)
Table 220 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Tool, 2022-2030 (USD Million)
Table 221 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by Deployment, 2022-2030 (USD Million)
Table 222 Rest of Middle East & Africa: Artificial Intelligence in Precision Medicine Market, by End-user, 2022-2030 (USD Million)
Table 223 Overview of Strategies Adopted by Key Players in AI Precision Medicine Market, January 2021-October 2024
Table 224 Artificial Intelligence in Precision Medicine Market: Degree of Competition
Table 225 Artificial Intelligence in Precision Medicine Market: Therapeutic Area Footprint, 2023
Table 226 Artificial Intelligence in Precision Medicine Market: End-user Footprint, 2023
Table 227 Artificial Intelligence in Precision Medicine Market: Component Footprint, 2023
Table 228 Artificial Intelligence in Precision Medicine Market: Deployment Footprint, 2023
Table 229 Artificial Intelligence in Precision Medicine Market: Region Footprint, 2023
Table 230 Artificial Intelligence in Precision Medicine Market: Detailed List of Key Startup/SME Players, 2023
Table 231 Artificial Intelligence in Precision Medicine Market: Competitive Benchmarking of Key Emerging Players/Startups, by Region, 2023
Table 232 Artificial Intelligence in Precision Medicine Market: Product Launches, January 2021-October 2024
Table 233 Artificial Intelligence in Precision Medicine Market: Deals, J Anuary 2021-October 2024
Table 234 Artificial Intelligence in Drug Discovery Market: Expansions, January 2021-October 2024
Table 235 Artificial Intelligence in Precision Medicine Market: Other Developments, January 2021-October 2024
Table 236 Nvidia Corporation: Company Overview
Table 237 Nvidia Corporation: Products/Services/Solutions Offered
Table 238 Nvidia Corporation: Product Launches
Table 239 Nvidia Corporation: Deals
Table 240 Exscientia: Company Overview
Table 241 Exscientia: Products/Services/Solutions Offered
Table 242 Exscientia: Product Launches
Table 243 Exscientia: Deals
Table 244 Exscientia: Expansions
Table 245 Exscientia: Other Developments
Table 246 Google: Company Overview
Table 247 Google: Products/Services/Solutions Offered
Table 248 Google: Product Launches
Table 249 Google: Deals
Table 250 Google: Expansions
Table 251 Illumina, Inc.: Company Overview
Table 252 Illumina, Inc.: Products/Services/Solutions Offered
Table 253 Illumina, Inc.: Product Launches
Table 254 Illumina, Inc.: Deals
Table 255 Tempus: Company Overview
Table 256 Tempus: Products/Services/Solutions Offered
Table 257 Tempus: Product Launches
Table 258 Tempus: Deals
Table 259 Tempus: Expansions
Table 260 Tempus: Other Developments
Table 261 Benevolentai: Company Overview
Table 262 Benevolentai: Products/Services/Solutions Offered
Table 263 Benevolentai: Deals
Table 264 Microsoft Corporation: Company Overview
Table 265 Microsoft Corporation: Products/Services/Solutions Offered
Table 266 Microsoft Corporation: Deals
Table 267 IBM: Company Overview
Table 268 IBM: Products/Services/Solutions Offered
Table 269 IBM: Deals
Table 270 GE Healthcare: Company Overview
Table 271 GE Healthcare: Products/Services/Solutions Offered
Table 272 GE Healthcare: Product Launches
Table 273 GE Healthcare: Deals
Table 274 GE Healthcare: Other Developments
Table 275 Deep Genomics: Company Overview
Table 276 Deep Genomics: Products/Services/Solutions Offered
Table 277 Deep Genomics: Product Launches
Table 278 Deep Genomics: Deals
Table 279 Deep Genomics: Other Developments
Table 280 Siemens Healthineers AG: Company Overview
Table 281 Siemens Healthineers AG: Products/Solutions/Services Offered
Table 282 Siemens Healthineers AG: Deals
Table 283 Bioxcel Therapeutics, Inc.: Company Overview
Table 284 Bioxcel Therapeutics, Inc.: Products/Solutions/Services Offered
Table 285 Bioxcel Therapeutics, Inc.: Deals
Table 286 Bioxcel Therapeutics, Inc.: Other Developments
Table 287 Insilico Medicine: Company Overview
Table 288 Insilico Medicine: Products/Services/Solutions Offered
Table 289 Insilico Medicine: Product Launches
Table 290 Insilico Medicine: Deals
Table 291 Insilico Medicine: Other Developments
Table 292 Pathai, Inc.: Company Overview
Table 293 Pathai, Inc.: Products/Services/Solutions Offered
Table 294 Pathai, Inc.: Product Launches
Table 295 Pathai, Inc.: Deals
Table 296 Pathai, Inc.: Other Developments
Table 297 Verge Genomics: Company Overview
Table 298 Verge Genomics: Products/Services/Solutions Offered
Table 299 Verge Genomics: Deals
Table 300 Guardant Health, Inc.: Company Overview
Table 301 Guardant Health, Inc.: Products/Services/Solutions Offered
Table 302 Guardant Health, Inc.: Product Launches
Table 303 Guardant Health, Inc.: Deals
Table 304 Guardant Health, Inc.: Other Developments
Table 305 Grail, Inc.: Company Overview
Table 306 Grail, Inc.: Products/Services/Solutions Offered
Table 307 Grail, Inc.: Deals
Table 308 Foundation Medicine, Inc.: Company Overview
Table 309 Foundation Medicine, Inc.: Products/Services/Solutions Offered
Table 310 Foundation Medicine, Inc.: Deals
Table 311 Foundation Medicine, Inc.: Other Developments
Table 312 Proscia Inc.: Company Overview
Table 313 Proscia Inc.: Products/Services/Solutions Offered
Table 314 Proscia Inc.: Product Launches
Table 315 Proscia Inc.: Deals
Table 316 Proscia Inc.: Other Developments
Table 317 Flatiron Health: Company Overview
Table 318 Flatiron Health: Products/Services/Solutions Offered
Table 319 Flatiron Health: Deals
Table 320 Flatiron Health: Other Developments
Table 321 Predictive Oncology: Company Overview
Table 322 Paige AI, Inc.: Company Overview
Table 323 Densitas Inc.: Company Overview
Table 324 Zephyr AI, Inc.: Company Overview
Table 325 Nucleai, Inc.: Company Overview

Figure 1 AI in Precision Medicine Market Segmentation & Regional Scope
Figure 2 Study Years Considered
Figure 3 Research Design
Figure 4 Primary Sources
Figure 5 Insights from Primary Experts
Figure 6 Breakdown of Primary Interviews (Demand Side), by Company Type, Designation, and Region
Figure 7 Market Size Estimation: Revenue Share Analysis
Figure 8 Top-Down Approach
Figure 9 CAGR Projections, by Market Dynamic, 2024-2030
Figure 10 CAGR Projections: Supply-Side Analysis
Figure 11 Data Triangulation
Figure 12 Artificial Intelligence in Precision Medicine Market, by Application, 2024 vs. 2030 (USD Million)
Figure 13 Artificial Intelligence in Precision Medicine Market, by Therapeutic Area, 2024 vs. 2030 (USD Million)
Figure 14 Artificial Intelligence in Precision Medicine Market, by Component, 2024 vs. 2030 (USD Million)
Figure 15 Artificial Intelligence in Precision Medicine Market, by Tool, 2024 vs. 2030 (USD Million)
Figure 16 Artificial Intelligence in Precision Medicine Market, by Deployment, 2024 vs. 2030 (USD Million)
Figure 17 Artificial Intelligence in Precision Medicine Market, by End-user, 2024 vs. 2030 (USD Million)
Figure 18 Artificial Intelligence in Precision Medicine Market: Geographical Snapshot
Figure 19 Growing Focus on Cost-Effective Processes and Favorable Government Support and Funding to Drive Market
Figure 20 North America to Dominate AI in Precision Medicine Market During Forecast Period
Figure 21 Pharmaceutical Companies in North America Accounted for Largest Market Share in 2023
Figure 22 India to Register Highest Growth Rate During Forecast Period
Figure 23 Emerging Markets to Register Higher Growth Rates During Forecast Period
Figure 24 Artificial Intelligence in Precision Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 25 Approval Rate of Personalized Medicines by US Fda, 2015-2023
Figure 26 Health Security Breaches, 2009-2023
Figure 27 Individuals Affected by Healthcare Security Breaches, 2009-2023 (Million)
Figure 28 Use Cases for Predictive Analytics in Healthcare
Figure 29 Revenue Shift in AI in Precision Medicine Market
Figure 30 AI in Precision Medicine Market: Ecosystem Analysis
Figure 31 AI in Precision Medicine Market: Value Chain Analysis, 2023
Figure 32 AI in Precision Medicine Market: Porter's Five Forces Analysis
Figure 33 Jurisdiction Analysis: Top Patent Applicant Countries, January 2015-November 2024
Figure 34 Key Patents in AI in Precision Medicine Market, January 2015- November 2024
Figure 35 Influence of Stakeholders on Buying Process for Top Three End-users
Figure 36 Key Buying Criteria for End-users
Figure 38 Market Potential of AI/Generative AI in Enhancing AI in Precision Medicine Across Industries
Figure 39 Impact of AI/Gen AI on Interconnected and Adjacent Ecosystems
Figure 40 North America: Artificial Intelligence in Precision Medicine Market Snapshot
Figure 41 Asia-Pacific: Artificial Intelligence in Precision Medicine Market Snapshot
Figure 42 Revenue Analysis of Key Players, 2019-2023 (USD Million)
Figure 43 Market Share Analysis of Key Players, 2023
Figure 44 Artificial Intelligence in Precision Medicine Market: Ranking of Key Players, 2023
Figure 45 Artificial Intelligence in Precision Medicine Market: Company Evaluation Matrix (Key Players), 2023
Figure 46 Artificial Intelligence in Precision Medicine Market: Company Footprint, 2023
Figure 47 Artificial Intelligence in Drug Discovery Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 48 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 49 EV/EBITDA of Key Vendors, 2024
Figure 50 Artificial Intelligence in Precision Medicine Market: Brand/Product Comparative Analysis
Figure 51 Nvidia Corporation: Company Snapshot
Figure 52 Exscientia: Company Snapshot
Figure 53 Google: Company Snapshot
Figure 54 Illumina, Inc.: Company Snapshot
Figure 55 Benevolentai: Company Snapshot
Figure 56 Microsoft Corporation: Company Snapshot
Figure 57 IBM: Company Snapshot
Figure 58 GE Healthcare: Company Snapshot
Figure 59 Siemens Healthineers AG: Company Snapshot
Figure 60 Guardant Health: Company Snapshot